CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net income (loss)	$ 576,544	$ (706,553)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	914,511	503,244
Inventory write-offs	140,000	156,844
Issuance of common stock for acquisition costs	0	0
Shares issued for services	175,000	127,500
Shares issued for finder fee	33,740	0
Bad debt expense	1,000	1,165
Loss on sale of equipment	0	6,292
Gain on forgiveness of SBA PPP loan	(300,995)	0
Stock based compensation	1,270,553	227,317
Changes in assets and liabilities, net of acquiried amounts
Accounts receivable	235,681	(12,358)
Inventory	(1,106,639)	(368,389)
Prepaid expenses and other assets	284,871	(151,455)
Change in deferred tax asset	177,674	0
Accounts payable and accrued liabilities	(1,184,302)	(319,068)
Deferred revenue	(5,029)	(133,860)
Net cash provided by (used in) operating activities	1,212,609	(669,321)
Cash flows from investing activities
Acquisition of VitaMedica	(2,074,589)	0
Acquisition of Infusionz, Inc., net of cash acquired	0	212,122
Acquisition of Interactive Offers, net of cash acquired	(1,854,193)
Proceeds from sale of property and equipment	0	64,000
Acquisition of property and equipment	(5,071,072)	(34,337)
Net cash (used in) provided by investing activities	(8,999,854)	241,785
Cash flows from financing activities
Proceeds from issuance of related party note payable	0	750,000
Repayment of notes payable	(151,004)	(12,000)
Net cash (used in) provided by financing activities	(151,004)	738,000
Net (decrease) increase in cash	(7,938,249)	310,464
Cash, beginning of period	14,534,211	887,517
Cash, end of period	6,595,962	1,197,981
Supplemental cash flow disclosures
Interest paid	0	0
Income tax paid	0	0
Non-cash financing activities
Issuance of common stock for acquisition of Infusionz	1,764,876	495,125
Issuance of common stock for acquisition of VitaMedica	482,000	0
Repayment of Infusionz LLC debt to Grove, Inc.	0	72,000
Issuance of debt for acquisition of VitaMedica	1,000,000	0
Liabilities assumed from acquisition of Infusionz	0	(680,480)
Liabilities assumed from acquisition of VitaMedica	(309,574)	0
Issuance of stock for acquisition of Interactive	4,000,000	0
Liabilities assumed from acquisition of Interactive	$ (1,099,993)	$ 0